| Patient | Nelson Mandela |
|---|---|
| Date of birth | 1918-07-18 |
| Identifiers | MRN HR-ML021-SYN-TD; SSN (made up) 000-21-6718 |
| Document date | 2001-03-10 |
| Author | Thandiwe Mokoena, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Man of 82 with newly diagnosed prostate adenocarcinoma, Grade Group 3, PSA 6.4 ng/mL, cT1c, NCCN unfavorable intermediate risk, found after a rising PSA on monitoring. Please advise on curative treatment, including radiotherapy with short-term androgen deprivation, and whether observation is reasonable at his age. [S]
Urgency: Routine, within four to six weeks. [S]
Questions for the consultant:
Fit and independent; walks every morning. Decades ago he had an operation that removed part of the prostate for benign enlargement with urinary blockage. Treated tuberculosis in the past, with no symptoms since. A rise in PSA on routine monitoring led to a multiparametric MRI (28 mL gland with a resection defect; 9 mm PI-RADS 4 lesion in the left peripheral zone; no extraprostatic extension) and an MRI-ultrasound fusion transperineal biopsy: Gleason 4+3 in 1 of 2 targeted cores (30 percent) and Gleason 3+4 in 2 of 12 systematic cores; 3 of 14 cores positive. Digital rectal examination: smooth, no nodule. PSA 6.4 ng/mL, testosterone 412 ng/dL, hemoglobin 14.1 g/dL, eGFR 69, alkaline phosphatase 74 U/L, A1c 5.5 percent, LDL 112 mg/dL, 25-hydroxyvitamin D 26 ng/mL. IPSS 7. PHQ-9 score 4. No regular medicines. PSMA PET/CT ordered; DXA booked for the day of the consultation [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
4 later historical claims are omitted because they describe events after the index age. See the teaching note.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Adenocarcinoma of the prostate, NCCN unfavorable intermediate risk: cT1c, Grade Group 3 (Gleason 4+3), PSA 6.4 ng/mL, 3 of 14 cores, found after a rising PSA; synthetic modern detail linked to his publicly announced prostate cancer | active | confirmed | C61 | S — Synthetic grade, PSA, core count, stage, and risk group; the PSA rise, the biopsy-proven localized cancer that was not high grade, hormone therapy, and curative radiotherapy are from his doctors' and spokeswoman's public statements (D). |
| Hormone-sensitive prostate cancer | active | confirmed | Z19.1 | S — Synthetic status in the modern episode. |
| History of pulmonary tuberculosis, treated, with no symptoms since | resolved | confirmed | Z86.11 | S — The 1988 tuberculosis is documented (D); the coding and the statement that it has not recurred are synthetic. |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 1985 | Operation on the prostate for an enlarged gland causing urinary blockage, with part of the gland removed (type of operation not recorded in the cited sources) | D (CLM-0003) |
| 12 August 1988 | Tuberculosis, diagnosed after admission to hospital and treated | D (CLM-0004) |
| November 2000 | Raised PSA found on routine monitoring, followed by a prostate biopsy | D (CLM-0005) |
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2001-03-10 | Body height | 183 | cm | S |
| 2001-03-10 | Body weight | 80.2 | kg | S |
| 2001-03-10 | Body mass index (BMI) [Ratio] | 23.9 | kg/m2 | S |
| 2001-03-10 | Systolic blood pressure | 132 | mm[Hg] | S |
| 2001-03-10 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2001-03-10 | Heart rate | 68 | /min | S |
| 2001-03-10 | Respiratory rate | 14 | /min | S |
| 2001-03-10 | Body temperature | 36.6 | Cel | S |
| 2001-03-10 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2001-03-10 | Prostate specific Ag [Mass/volume] in Serum or Plasma | 6.4 | ng/mL | <=4 ng/mL | High | S |
| 2001-03-10 | Testosterone [Mass/volume] in Serum or Plasma | 412 | ng/dL | 264 to 916 ng/dL in adult men; below 50 ng/dL is the castrate target on androgen deprivation | Normal | S |
| 2001-03-10 | Hemoglobin [Mass/volume] in Blood | 14.1 | g/dL | 13.2-16.6 g/dL | Normal | S |
| 2001-03-10 | Leukocytes [#/volume] in Blood by Automated count | 5.8 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 2001-03-10 | Platelets [#/volume] in Blood by Automated count | 226 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 2001-03-10 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 2001-03-10 | Potassium [Moles/volume] in Serum or Plasma | 4.4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2001-03-10 | Glucose [Mass/volume] in Serum or Plasma | 94 | mg/dL | 70-99 mg/dL | Normal | S |
| 2001-03-10 | Creatinine [Mass/volume] in Serum or Plasma | 1.08 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2001-03-10 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1996)/1.73 sq M | 69 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2001-03-10 | Calcium [Mass/volume] in Serum or Plasma | 9.4 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 2001-03-10 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 18 | U/L | 7-55 U/L | Normal | S |
| 2001-03-10 | Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma | 74 | U/L | 40-129 U/L | Normal | S |
| 2001-03-10 | Albumin [Mass/volume] in Serum or Plasma | 4.1 | g/dL | 3.5-5 g/dL | Normal | S |
| 2001-03-10 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.5 | % | <=5.6% | Normal | S |
| 2001-03-10 | Cholesterol [Mass/volume] in Serum or Plasma | 184 | mg/dL | <=200 mg/dL | Normal | S |
| 2001-03-10 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 52 | mg/dL | >=40 mg/dL | Normal | S |
| 2001-03-10 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 112 | mg/dL | <=129 mg/dL | Normal | S |
| 2001-03-10 | Triglyceride [Mass/volume] in Serum or Plasma | 98 | mg/dL | <=149 mg/dL | Normal | S |
| 2001-03-10 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 26 | ng/mL | 30-100 ng/mL | Low | S |
| 2001-03-10 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | S | ||
| 2001-03-10 | International Prostate Symptom Score [IPSS] | 7 | {score} | S |